How to buy Boston Scientific (BSX) stocks

Boston Scientific is a medical devices business based in the US. Boston Scientific shares (BSX) are listed on the NYSE and all prices are listed in US Dollars.

Its last market close was $88.95 – a decrease of 1.29% over the previous week. Boston Scientific employs 48,000 staff and has a trailing 12-month revenue of around $15.9 billion.

Our top picks for where to buy Boston Scientific stock

Buy Boston Scientific stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Boston Scientific stock price (NYSE: BSX)

Use our graph to track the performance of BSX stocks over time.

Boston Scientific stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$88.95
52-week range	$55.60 - $91.93
50-day moving average more info button	$88.10
200-day moving average more info button	$78.48
Wall St. target price	$99.00
PE ratio more info button	72.7521
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$1.21

Is it a good time to buy Boston Scientific stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Boston Scientific price performance over time

Historical closes compared with the close of $88.66 from 2024-12-19

1 week (2024-12-13)	-1.61%
1 month (2024-11-22)	-1.49%
3 months (2024-09-20)	5.65%
6 months (2024-06-21)	14.09%

1 year (2023-12-21)	59.32%
2 years (2022-12-21)	92.40%
3 years (2021-12-21)	115.67%
5 years (2019-12-20)	95.42%

Is Boston Scientific stock undervalued or overvalued?

Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Boston Scientific's P/E ratio

Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 73x. In other words, Boston Scientific shares trade at around 73x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

Boston Scientific's PEG ratio

Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6394. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Boston Scientific's EBITDA

Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.1 billion.

The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.

Boston Scientific financials

Revenue TTM	$15.9 billion
Operating margin TTM	17.06%
Gross profit TTM	$8.7 billion
Return on assets TTM	4.9%
Return on equity TTM	8.92%
Profit margin	11.26%
Book value	$14.05
Market Capitalization more info button	$129.7 billion

TTM: trailing 12 months

Boston Scientific's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Boston Scientific's total ESG risk score

Total ESG risk: 29.23

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 12/31/2018) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Boston Scientific's environmental score

Environmental score: 1.51/100

Boston Scientific's social score

Social score: 12.87/100

Boston Scientific's governance score

Governance score: 7.87/100

Boston Scientific's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Boston Scientific Corp was last rated for ESG on: 2019-01-01.

Total ESG score	29.23
Total ESG percentile	56.94
Environmental score	1.51
Social score	12.87
Governance score	7.87
Level of controversy	3

Boston Scientific stock dividends

We're not expecting Boston Scientific to pay a dividend over the next 12 months.

Have Boston Scientific's stocks ever split?

Boston Scientific's stocks were split on a 2:1 basis on 5 November 2003 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for Boston Scientific stocks, which in turn could have impacted Boston Scientific's stock price.

Boston Scientific stock price volatility

Over the last 12 months, Boston Scientific's stocks have ranged in value from as little as $55.6 up to $91.93. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.797. This would suggest that Boston Scientific's stocks are less volatile than average (for this exchange).

Boston Scientific overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts..

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Boston Scientific is owned by insiders or institutions?
Currently 0.175% of Boston Scientific stocks are held by insiders and 92.602% by institutions. How many people work for Boston Scientific?
Latest data suggests 48,000 work at Boston Scientific. When does the fiscal year end for Boston Scientific?
Boston Scientific's fiscal year ends in December. Where is Boston Scientific based?
Boston Scientific's address is: 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 What is Boston Scientific's ISIN number?
Boston Scientific's international securities identification number is: US1011371077 What is Boston Scientific's CUSIP number?
Boston Scientific's Committee on Uniform Securities Identification Procedures number is: 101137107

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.